UK’s QuantuMDx Invests £11M To Bring Forward Launch Of Rapid, Point-Of-Care DNA Analyzer
Executive Summary
The COVID-19 pandemic has accelerated development of another new molecular diagnostic technology.
You may also be interested in...
INTERVIEW: QuantuMDx aims to be Apple of diagnostic industry's eye
As far as aspirations go, QuantuMDx is setting its sights high. The UK diagnostics start-up is still in the early stages of product development but one thing CEO Elaine Warburton has set her mind on is ensuring the company’s “lab-in-your-hand” device will emulate the sleek, simple and user-friendly designs that are iconic of the information technology giant Apple.
Exec Chat: Signifier Medical Investing In ‘Daytime-Only Treatments’ And Diagnostics For Sleep Apnea
The UK-based company is seeking to raise a further $100m in 2021 following the recent US clearance of its first product, a daytime-use neurostimulation device for snoring and mild obstructive sleep apnea.
Cantel Medical Snapped Up By Steris For $3.6Bn
The deal combines two of the largest providers of sterilization and infection-prevention products to create a $4bn-plus-revenue business.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: